Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based ...

The annual meeting of the American College of Cardiology was held from March 29 to 31 in Chicago and attracted more than ...

Patients with pulmonary arterial hypertension (PAH) can develop several complications with the progression of the disease or as a result of hemodynamic imbalance. Some of these complications include ...